Oramed Pharmaceuticals Inc. (ORMP) financial statements and ratios from SEC XBRL: revenue $2.00M (TTM), net margin 3202.5%, P/E 3.9. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.00M |
| Net Margin | 3202.5% |
| P/E Ratio | 3.9 |
| Price / Book | 0.63 |
| Price / Sales | 37.39 |
| FCF Yield | -4.1% |
| Altman Z-Score | 3.38 (safe) |
| Sector P/E (Healthcare) | 21.7 |
ORMP overview · ORMP earnings · ORMP KPIs · ORMP investor relations · ORMP ownership · ORMP peers · ORMP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.